The No Surprises Act has protected patients from surprise medical bills. However, the law’s incentives for insurers acting as ...

There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...

While recent fertility drug-related announcements by the Trump administration could result in savings for women—especially ...

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...

Health Affairs' Jeff Byers welcomes Allison Oakes, Chief Research Officer of Trilliant Health, to the pod to discuss ...

The North Carolina State Health Plan experience shows us that large, self-insured employers can work to bend the cost curve ...

Language services are essential for health equity and good patient health outcomes, but recent executive actions threaten to ...

For now, the most reasonable stance is watchful waiting: acknowledging the real problems WISeR seeks to address, recognizing ...

ICHRAs are a fascinating experiment that could open the door to a new phase of US health policy, but benefiting from an ...

Despite its age, the classic medical adage of “first, do no harm” is precisely the guiding philosophy that artificial ...

This Forefront article details the proposed changes to Medicaid eligibility and financing, the anticipated outcomes for ...

A patient-led process for comparing actual bills to data reported under the hospital price transparency rule would help the ...